Related Experiment Video
Updated: Jun 29, 2026
09:54
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Retroviral immunology: lessons from a mouse model.
1Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, 903 S. 4th St, Hamilton, MT 59840, USA.
Immunologic Research
|October 3, 2008
Summary
Friend virus (FV) causes lethal erythroleukemia in mice. Understanding immune responses to FV infection aids in developing vaccines and therapeutics for retroviral diseases like HIV-1.
Area of Science:
- Immunology
- Virology
- Oncology
Background:
- Friend virus (FV) is a murine retrovirus causing lethal erythroleukemia in mice.
- FV infection models reveal crucial immune responses for disease control.
- Insights from FV are relevant to human retroviral infections like HIV-1 and HTLV-1.
Purpose of the Study:
- To elucidate the immune responses necessary for recovery from acute FV infection.
- To understand the mechanisms controlling chronic FV infection.
- To leverage FV model knowledge for human retroviral disease therapeutics.
Main Methods:
- Murine models of Friend virus infection.
- Analysis of immune responses during acute and chronic phases.
- Evaluation of vaccine and therapeutic strategies.
Main Results:
- Identified specific immune responses critical for acute FV infection recovery.
- Characterized immune mechanisms maintaining long-term control of chronic FV infection.
- Demonstrated the translational relevance of FV research to human retroviral infections.
Conclusions:
- The FV model is pivotal for understanding retroviral pathogenesis and immune control.
- Knowledge gained from FV research informs the development of novel vaccines and therapies.
- FV research provides critical immunological insights applicable to human retroviral infections such as HIV-1 and HTLV-1.
